Clinical Trials for Almac

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Almac

Clinical Trials (3)

APOL1 Genotyping CTA Clinical Performance Study

1,000 participants

Started: Mar 6, 2025 · Completed: Mar 31, 2026

1 condition1 sponsor1 location

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

PHASE2Recruiting

60 participants

Started: Dec 21, 2023 · Completed: Jan 31, 2027

2 conditions4 sponsors15 locations

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

PHASE2Active, not recruiting

63 participants

Started: Feb 14, 2022 · Completed: Nov 30, 2024

3 conditions5 sponsors21 locations